Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

ovarian serous adenocarcinoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

ovarian serous adenocarcinoma

MONDO:0005211

Also known as:ovarian serous carcinomaovary serous adenocarcinomaserous adenocarcinoma of ovary

Find Clinical TrialsTrials

Overview

An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia.

Clinical Trials36 registered · 4 recruiting

Diagnosis

Biomarker and diagnostic research for ovarian serous adenocarcinoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

36 clinical trials registered, 4 recruiting. Interventions under study include drug therapy, other interventions, biologic therapy, and procedural interventions. Pipeline includes 5 PHASE3, 12 PHASE2, 12 PHASE1. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05329532](https://clinicaltrials.gov/study/NCT05329532)

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:02 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 36 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Patient case studies	38	30%
Testing and diagnosis research	27	21%
Laboratory research	26	21%
Research summaries	13	10%
Disease patterns and progression	10	8%
Clinical study results	8	6%
New treatment approaches	3	2%
Other research	1	1%

ovarian serous adenocarcinoma

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications